CSTL

CASTLE BIOSCIENCES, INC.

CSTL · CIK 1447362 · Annual (10-K) · Last 7 years

Financial Trends

Revenue$344M
20192025
Net Income−$24M
20192025
Operating CF$64M
20192025
Free Cash Flow$28M
20192025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue$0.3B$0.3B$0.2B$0.1B$0.1B$0.0B$0.0B
Cost of Revenue$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
Gross Profit—————$0.0B$0.0B
R&D Expense$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.2B$0.2B$0.2B$0.1B$0.1B$0.0B$0.0B
Operating Income$-0.0B$0.0B$-0.1B$-0.1B$-0.0B$-0.0B$0.0B
Net Income$-0.0B$0.0B$-0.1B$-0.1B$-0.0B$-0.0B$0.0B
EPS (Basic)$-0.83$0.66$-2.14$-2.58$-1.24$-0.23$0.12
EPS (Diluted)$-0.83$0.62$-2.14$-2.58$-1.24$-0.23$0.11

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.6B$0.5B$0.5B$0.4B$0.5B$0.4B$0.1B
Current Assets$0.4B$0.4B$0.3B$0.3B$0.4B$0.4B$0.1B
Cash & Equivalents$0.1B$0.1B$0.1B$0.1B$0.3B$0.4B$0.1B
Total Liabilities$0.1B$0.1B$0.1B$0.0B$0.1B$0.0B$0.0B
Current Liabilities$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.5B$0.5B$0.4B$0.4B$0.4B$0.4B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$0.1B$0.1B$-0.0B$-0.0B$-0.0B$0.0B$0.0B
Investing Cash Flow$-0.1B$-0.1B$-0.0B$-0.2B$-0.1B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$0.0B$-0.0B$0.0B$0.0B$0.3B$0.1B
← Companies